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Additional file 3: Comparison of study participants and non-responders regarding the chance for study 
participation: results from multilevel logistic regression analysis allowing for random 








Gender: male 40.7% 35.1%
[n=3,850] 1,16 [1,09-1,24] < 0.001




Diagnosis groups used for patient inclusion
- Joint arthrosis  38.1% 35.7% 1,13 [1,06-1,20] < 0.001
- Diabetes mellitus 36.9% 40.1% 0,92 [0,86-0,99] 0.017
- Thyroid dysfunction 32.4% 31.5% 1,09 [1,01-1,17] 0.031
- Chronic ischemic heart disease 30.9% 30.3% 1,03 [0,95-1,11] 0.475
- Cardiac arrhythmias  26.2% 24.3% 1,10 [1,00-1,19] 0.039
- Asthma/COPD 24.3% 23.4% 1,05 [0,96-1,15] 0.261
- Cancers 21.8% 19.6% 1,10 [0,99-1,21] 0.065
- Lower limb varicosis 21.7% 22.7% 0,95 [0,86-1,05] 0.338
- Osteoporosis  19.0% 17.9% 1,17 [1,05-1,30] 0.005
- Atherosclerosis/PAOD 17.7% 16.4% 1,01 [0,90-1,13] 0.882
- Severe vision reduction 16.4% 15.9% 1,08 [0,96-1,21] 0.213
- Depression 15.3% 17.4% 0,93 [0,83-1,05] 0.238
- Neuropathies 14.8% 13.8% 1,13 [1,00-1,28] 0.055
- (Alcoholic) liver diseases and alcohol abuse 13.1% 14.4% 0,83 [0,72-0,95] 0.006
- Intestinal diverticulosis  12.3% 8.5% 1,39 [1,20-
1,60] < 0.001
- Cardiac insufficiency  10.6% 11.5% 0,96 [0,83-1,11] 0.611
- Cerebral ischemia/Chronic stroke 10.4% 9.7% 1,07 [0,92-1,25] 0.362
- Renal insufficiency 9.6% 9.1% 1,05 [0,89-1,23] 0.554
- Cardiac valve disorders 8.8% 7.2% 1,18 [0,99-1,39] 0.064
- Urinary incontinence  6.0% 6.0% 1,14 [0,93-1,39] 0.196
- Somatoform disorders 5.9% 6.3% 0,90 [0,73-1,10] 0.292
- Dizziness 5.6% 5.7% 1,03 [0,83-1,26] 0.802
- Severe hearing loss 5.1% 5.0% 0,99 [0,79-1,23] 0.902
- Anemias 4.9% 4.9% 1,04 [0,83-1,29] 0.762
- Anxiety 4.1% 4.4% 0,89 [0,69-1,13] 0.337
- Migraine 3.7% 3.8% 0,98 [0,76-1,27] 0.905
- Psoriasis 3.7% 2.7% 1,35 [1,03-
1,77] 0.031
- Rheumatoid arthritis/Chronic polyarthritis 3.5% 3.6% 1,00 [0,77-1,30] 0.984
- Parkinson’s disease 1.9% 1.4% 1,40 [0,95-2,05] 0.088
n: number of observations; 95% CI: 95% confidence interval; * statistically significant (p ≤ 0.05) and 
clinically relevant results (RR ≤ 0.75 and ≥ 1.25, respectively) in italic and bold letters.